Product Images Pramipexole Dihydrochloride

This is a medication in tablet form containing Pramipexole Dihydrochloride, an active ingredient which is released gradually over time. The recommended dose is one tablet per day to be swallowed whole and not crushed or divided. It is manufactured by Cadila Healthcare Limited in India and must be stored under controlled room temperature to protect from exposure to humidity. The packaging includes patient information that should be provided alongside each prescription.*

This is a medication, Pramipexole Dihydrochloride, in extended-release tablet form with a strength of 0.75 mg. The recommended dosage can be found in the package insert, and tablets must not be chewed, crushed, or divided. The medication should be stored between 20° to 25°C and away from high humidity. This drug product should be kept away from children. Manufactured by Cadila Healthcare Ltd in Ahmedabad, India. Patient information is provided separately to each patient.*

ZyGenerics is a medication that contains 1.5mg of pramipexole dihydrochloride in extended-release tablets, dispensed in an original unit of use container with 30 tablets. The tablets must be swallowed whole and not chewed, crushed or divided. It is recommended to store the medication at 20° to 25°C (68° to 77°F) to protect it from high humidity. The information provided must be given separately to each patient by the pharmacist. The manufacturer is Cadila Healthcare Ltd, located in Ahmedabad, India.*

This is a medication with the NDC code 70774-1331-3 that contains 30 extended-release tablets of Pramipexole Dihydrochloride for oral use. Each tablet contains 225 mg of Pramipexole dihydrochloride, and it's recommended to be swallowed whole, not chewed, crushed, or divided. The package insert must be consulted for complete prescribing information. It should be stored at between 20°C and 25°C to protect it from high humidity, and it must be kept out of the reach of children. The medication is manufactured by Cadia Healthcare Ltd. in Ahmedzbad, India.*

This is a medication called Ramipexole Dihydrochloride, an extended-release tablet prescribed for patients with Parkinson's disease. Each tablet contains 3mg of the medication, and it is meant to be taken once daily. The tablets come in a container, which should be given to the patient along with patient information by the pharmacist. The recommended dosage should be followed as directed in the package insert. The tablets should be swallowed whole, not crushed or divided, and stored at room temperature, protected from high humidity. This medication is manufactured by Cadila Healthcare L. in Ahmedabad, India.*

This is a prescription medication with the NDC code 70771-13333. The medication is Pramipexole Dihydrochloride Extended-release Tablets to be taken once daily. Each tablet contains 375mg of Pramipexole dihydrochloride. Tablets should be swallowed whole and not chewed, crushed, or divided. The usual dosage instructions and complete prescribing information can be found in the package insert. The medication should be stored at 20° to 25°C (68°F to 77°F) and protected from exposure to high humidity. This product was manufactured by Cadia Healthcare Ltd. in Ahmedabad, India. Information is provided separately to each patient.*

This is a description of a medication called Pramipexole Dihydrochloride Extended-release Tablets. It is typically taken once daily and comes in 30 tablet packages. Each tablet contains 4.5mg of pramipexole difhydrochioride, USP (Monohydrate). The instructions state that the tablets must be swallowed whole and not chewed, crushed, or divided. The medication should be stored at 20° to 25°C (68° to 77°F) and must be kept out of the reach of children. The manufacturer is Cadila Healthcare Ltd in Abmedabad, India. Further dosage instructions are provided in the package insert.*